NIT
BBIO icon

NumerixS Investment Technologies’s BridgeBio Pharma BBIO Stock Holding History

NumerixS Investment Technologies’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,800
Closed -$59K – 95
2020
Q2 		$59K Buy
+1,800
New +$54.8K 0.02% 754
2020
Q1 		– Sell
-1,600
Closed -$56K – 999
2019
Q4 		$56K Buy
+1,600
New +$44.4K 0.01% 792

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NumerixS Investment Technologies's BBIO Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of BridgeBio Pharma (BBIO) in Q3 2020, closing a stake of 1,800 shares — an estimated $59K sold.

NumerixS Investment Technologies first reported a position in BBIO in Q4 2019 and held it in 2 quarters. The position peaked at $59K in Q2 2020. 129 funds tracked by Wall St. Rank hold BBIO as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining BridgeBio Pharma position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,800 BridgeBio Pharma shares in Q3 2020, an estimated $59K.
  • NumerixS Investment Technologies first reported a position in BridgeBio Pharma in Q4 2019 and held it in 2 quarters.
  • NumerixS Investment Technologies's BridgeBio Pharma position peaked at $59K in Q2 2020.
  • 129 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.